Publication | Closed Access

PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer

Cancer ImmunosurveillancePd-l1 ExpressionAggressive Malignant PotentialImmunologyTumor ImmunityBronchial NeoplasmImmune Checkpoint InhibitorM2 TamLung CancerImmunotherapyMedicineRadiation OncologyTumor Microenvironment